Monthly Archives: March 2011
Scientists have led an international team to discover new treatments for a rare and potentially lethal childhood disease that is the clinical opposite of diabetes mellitus.
An inexpensive type 2 diabetes drug that has been around for more than 15 years works just as well and has fewer side effects than a half-dozen other, mostly newer and more expensive classes of medication used to control diabetes.
Nestle Prepared Foods Company is recalling approximately 10,260 pounds of frozen spaghetti and meatball entrees that may contain foreign materials.
Patients with both type 1 diabetes and CKD have an increased risk of adverse outcomes. Despite aggressive treatment, many patients with type 1 diabetes and overt nephropathy develop End-Stage Renal Disease and/or succumb to a premature death.
Transplanting human umbilical cord blood-derived endothelial progenitor cells (EPCs) has been found to "significantly accelerate" wound closure in test models.
Doctors are increasingly using a convenient blood glucose test for diagnosing diabetes and pre-diabetes, but a study shows it's not the best way to diagnose diabetes in children.
A recent study found that individuals with fatty liver were five times more likely to develop type 2 diabetes than those without fatty liver.
A simple home urine test has been developed which can measure if patients with Type 1 and Type 2 diabetes are producing their own insulin.
The death of insulin-producing beta cells in the pancreas is a core defect in diabetes. Scientists in Italy and Texas now have discovered a new way that these cells die - by toxic imbalance of a molecule secreted by other pancreatic cells.
A multinational study has identified a key gene mutation responsible for type 2 diabetes in nearly 10 percent of patients of white European ancestry.
In the 1960s, a group of U.S. states with high age-adjusted stroke mortality defined a stroke belt. Until recently, geographic patterns of diabetes had not been specifically characterized in the same manner.
Researchers announced today in the American Journal of Epidemiology that despite the high level of spending on healthcare in the United States compared to England, Americans experience higher rates of chronic disease and markers of disease than their English counterparts at all ages.